Screen
Collect established biometric and lifestyle measures through a convenient on-site experience.
A screening result employees actually understand.
HeartAge transforms traditional biometric screenings into one clear, relatable result that gives employees a meaningful view of their cardiovascular risk and a practical starting point for action.
We measure established cardiovascular risk factors, calculate risk with a validated equation, and explain the result as a personal HeartAge.
What we measureBlood pressure, cholesterol, glucose, body measurements, and relevant health history
What employees receiveA personal HeartAge result with a clear explanation of the factors influencing it
What employers receiveAggregate workforce insights, participation data, and actionable population health trends
What makes HeartAge differentOne relatable result that helps employees understand risk and know where to start
How HeartAge works
A familiar screening process with a clearer outcome.
HeartAge builds on the biometric measures employers already recognize, including blood pressure, cholesterol, glucose, body measurements, smoking status, and relevant health history.
Those inputs are applied to a validated cardiovascular risk equation and translated into a personal HeartAge result that is easier to explain, remember, and act on.
Calculate
Apply an appropriate validated cardiovascular risk equation to each participant’s results.
Personalize
Translate the risk estimate into a personal HeartAge with clear context around the factors influencing it.
Guide
Provide practical next steps and encourage appropriate follow-up based on the participant’s results.
Built for employers
Measure whether your wellness program is actually reducing risk.
Traditional biometric screenings repeat the same tests and report isolated numbers. HeartAge uses guideline-based screening and validated cardiovascular risk equations to show employees what their results mean and help employers measure whether workforce risk is improving over time.
Guideline-based screening
Testing is based on age, risk, prior results, and USPSTF recommendations instead of repeating the same panel for every employee every year.
A result employees understand
HeartAge turns multiple clinical measurements into one clear result that makes cardiovascular risk easier to understand, remember, and act on.
Risk measured over time
Compare calculated cardiovascular risk across screening cycles to see whether employee risk is improving, worsening, or staying the same.
A stronger way to demonstrate impact
Show aggregate movement in workforce cardiovascular risk instead of relying only on participation rates, isolated biometrics, or medical claims.
Why HeartAge works
A simple way to talk about a serious risk.
The CDC has used “heart age” to help people understand how factors such as high blood pressure, cholesterol, smoking, diabetes, and weight contribute to heart attack and stroke risk.
Watch the CDC Vital Signs video, “Is Your Heart Older Than You?”
Clinical evidence
Established risk science, translated for understanding.
HeartAge is grounded in established cardiovascular risk science. The Framingham General Cardiovascular Disease Risk Profile estimates 10-year cardiovascular risk using routinely collected factors such as age, blood pressure, cholesterol, smoking, and diabetes status.[1]
CDC researchers later used the sex-specific Framingham Risk Score to calculate predicted heart age. Heart age represents the age of a person with the same estimated cardiovascular risk but with risk factors at normal levels.[2] The CDC presented the concept as a practical way to communicate risk for heart attack and stroke.
Our screening approach focuses on established cardiovascular risk factors and uses screening recommendations to guide which measurements are appropriate for each participant. Blood pressure screening is included because the USPSTF recommends screening adults age 18 and older for hypertension, with diagnostic confirmation outside the screening setting when an elevated result is identified.[4]
Scope: HeartAge communicates estimated cardiovascular risk. It does not diagnose cardiovascular disease, replace diagnostic testing or clinical judgment, or imply endorsement by the CDC, USPSTF, ACC, or AHA.
Source documentation
Clinical references
- D'Agostino RB Sr, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579.
- Yang Q, et al. Vital Signs: Predicted heart age and racial disparities in heart age among U.S. adults at the state level. MMWR. 2015;64(34):950-958.
- Goff DC Jr, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129(25 Suppl 2):S49–S73. doi:10.1161/01.cir.0000437741.48606.98.
- U.S. Preventive Services Task Force. Hypertension in Adults: Screening. 2021.
- U.S. Preventive Services Task Force. Cardiovascular disease: risk assessment with nontraditional risk factors. Final recommendation statement. 2018.
Multi-year cost planning
Stop repeating the same bloodwork for everyone, every year.
Traditional biometric screening programs often repeat cholesterol testing across the full workforce annually. HeartAge establishes a baseline in year one, then uses age, prior results, cardiovascular risk factors, and program criteria to identify which participants may need updated bloodwork.
Every participant can still complete an annual HeartAge screening. The difference is that repeat laboratory testing is focused rather than automatically repeated for everyone.
Estimated three-year cost range
$2,500 to $5,500 lower Approximately 7% to 16% lower over three yearsYearHeartAgeTraditional
Planning estimate only. Actual pricing, laboratory eligibility, and clinical follow-up depend on workforce characteristics, prior results, program design, and the percentage of participants requiring updated testing.
Why testing frequency may change
HeartAge does not assume that every employee requires the same laboratory panel every year. Repeat testing considers prior results, age, cardiovascular risk factors, relevant health history, and the requirements of the risk equation being used.
Current USPSTF cardiovascular prevention guidance evaluates cholesterol alongside other risk factors such as hypertension, diabetes, and smoking when estimating cardiovascular risk. It does not establish annual cholesterol testing for every asymptomatic adult. Earlier USPSTF lipid-screening guidance discussed longer intervals for people with repeatedly normal results, although that guidance is now archived.
Why we exist
Understanding risk is the first step toward changing it.
HeartAge exists to make cardiovascular risk easier to understand and prevention easier to act on. We bring evidence-based screening into workplaces and communities through a clear, engaging experience built around one meaningful result.
Our mission is to help more people recognize their risk earlier, understand the factors influencing it, and take appropriate next steps toward better heart health.
Employees get clarity
Your workforce receives a clear, evidence-based view of cardiovascular risk that is easier to understand and remember.
Communities gain access
Organizations can sponsor free HeartAge screening days through our mobile screening unit, bringing prevention directly to the people and places that need it.
Explore community screenings →Prevention reaches further
HeartAge supports workplace wellness, public screening events, and community health partnerships through one adaptable screening model.
For benefits and wellness leaders
Bring smarter cardiovascular screening to your workforce.
Give employees a clearer understanding of their cardiovascular risk while giving your organization a more focused screening strategy and a measurable way to track change over time.
Explore community screening sponsorships →Common questions
HeartAge, explained.
What is HeartAge?
HeartAge is a simple expression of estimated cardiovascular risk. It compares a participant’s calculated risk with the risk associated with a healthier reference profile and communicates the difference as an age.
Is HeartAge clinically validated?
HeartAge is calculated using established cardiovascular risk models and routinely collected risk factors. The result is designed to make an evidence-based risk estimate easier to understand and communicate.
Is this a medical diagnosis?
No. HeartAge is a screening and risk-communication tool. It does not diagnose cardiovascular disease or replace diagnostic testing, clinical judgment, or care from a qualified healthcare professional.
How does HeartAge use preventive-care guidance?
HeartAge considers factors such as age, previous results, health history, and cardiovascular risk when determining which screening measurements may be appropriate. This avoids automatically repeating the same bloodwork for every participant each year.
Can employers track whether risk is changing?
Yes. Aggregate cardiovascular risk and HeartAge results can be compared across screening cycles to show whether workforce risk is improving, worsening, or remaining stable. Employers never receive an individual employee’s private results.
Does every employee need bloodwork every year?
Not necessarily. HeartAge establishes baseline results and uses participant-specific information to guide repeat testing rather than automatically repeating the same laboratory panel across the entire workforce.
Do you also offer community screenings?
Yes. Hospitals, employers, and community organizations can sponsor free public HeartAge screening events through our mobile screening unit.
Explore community screenings →